349 related articles for article (PubMed ID: 32704373)
1. Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.
Kaufman CL; Kanitakis J; Weissenbacher A; Brandacher G; Mehra MR; Amer H; Zelger BG; Zelger B; Pomahac B; McDiarmid S; Cendales L; Morelon E
SAGE Open Med; 2020; 8():2050312120940421. PubMed ID: 32704373
[TBL] [Abstract][Full Text] [Related]
2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
3. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the rat hind limb transplant as an experimental model of vascularized composite allotransplantation: Approaches and advantages.
Fleissig YY; Beare JE; LeBlanc AJ; Kaufman CL
SAGE Open Med; 2020; 8():2050312120968721. PubMed ID: 33194200
[TBL] [Abstract][Full Text] [Related]
5. Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changes.
Cendales LC; Farris AB; Rosales I; Elder D; Gamboa-Dominguez A; Gelb B; Issa F; Ravindra K; Nankivell BJ; Talbot S; Xu XG; Moris D; Drachenberg CB; Kanitakis J; Selim MA
Am J Transplant; 2024 May; 24(5):716-723. PubMed ID: 38286355
[TBL] [Abstract][Full Text] [Related]
6. A critical analysis of rejection in vascularized composite allotransplantation: clinical, cellular and molecular aspects, current challenges, and novel concepts.
Sarhane KA; Tuffaha SH; Broyles JM; Ibrahim AE; Khalifian S; Baltodano P; Santiago GF; Alrakan M; Ibrahim Z
Front Immunol; 2013 Nov; 4():406. PubMed ID: 24324470
[TBL] [Abstract][Full Text] [Related]
7. Chronic Allograft Deterioration: A Clinical Reality in Vascularized Composite Allotransplantation.
Krezdorn N; Pomahac B
Am J Transplant; 2017 Jul; 17(7):1703-1704. PubMed ID: 28371193
[No Abstract] [Full Text] [Related]
8. Vascularized composite allograft-specific characteristics of immune responses.
Issa F
Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
[TBL] [Abstract][Full Text] [Related]
9. Novel immunological and clinical insights in vascularized composite allotransplantation.
Kollar B; Pomahac B; Riella LV
Curr Opin Organ Transplant; 2019 Feb; 24(1):42-48. PubMed ID: 30531538
[TBL] [Abstract][Full Text] [Related]
10. Is Skin the Most Allogenic Tissue in Vascularized Composite Allotransplantation and a Valid Monitor of the Deeper Tissues?
Robbins NL; Wordsworth MJ; Parida BK; Kaplan B; Gorantla VS; Weitzel EK; Breidenbach WC
Plast Reconstr Surg; 2019 Apr; 143(4):880e-886e. PubMed ID: 30921156
[TBL] [Abstract][Full Text] [Related]
11. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
[TBL] [Abstract][Full Text] [Related]
12. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of the Reported Complications Related to Facial and Upper Extremity Vascularized Composite Allotransplantation.
Milek D; Reed LT; Echternacht SR; Shanmugarajah K; Cetrulo CL; Lellouch AG; Langstein HN; Leckenby JI
J Surg Res; 2023 Jan; 281():164-175. PubMed ID: 36162189
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
[TBL] [Abstract][Full Text] [Related]
15. Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation.
Weissenbacher A; Cendales L; Morelon E; Petruzzo P; Brandacher G; Friend PJ; Gorantla V; Kaufman C; Krapf J; Levin LS; Vrakas G; Schneeberger S
Transplantation; 2018 Aug; 102(8):1250-1252. PubMed ID: 29620616
[TBL] [Abstract][Full Text] [Related]
16. Chronic rejection in vascularized composite allografts.
Mundinger GS; Drachenberg CB
Curr Opin Organ Transplant; 2014 Jun; 19(3):309-14. PubMed ID: 24811439
[TBL] [Abstract][Full Text] [Related]
17. Existing and Evolving Bioethical Dilemmas, Challenges, and Controversies in Vascularized Composite Allotransplantation: An International Perspective From the Brocher Bioethics Working Group.
Magill G; Benedict J; Plock JA; Krones T; Gorantla VS;
Transplantation; 2019 Sep; 103(9):1746-1751. PubMed ID: 31283672
[TBL] [Abstract][Full Text] [Related]
18. Vascularized Composite Allotransplantation in Burn Reconstruction: Systematic Review and Meta-analysis.
Gray KM; Peterson JM; Padilla PL; Smith JM; Zapata-Sirvent RL; Branski LK; Norbury WB; Dziewulski P
J Burn Care Res; 2021 May; 42(3):465-472. PubMed ID: 33091131
[TBL] [Abstract][Full Text] [Related]
19. Living Donation of Vascularized Composite Allografts.
Pomahac B; Alhefzi M; Bueno EM; McDiarmid SV; Levin LS
Plast Reconstr Surg; 2018 Sep; 142(3):405e-411e. PubMed ID: 29927830
[TBL] [Abstract][Full Text] [Related]
20. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
